LUPINI, Laura
 Distribuzione geografica
Continente #
NA - Nord America 2.735
EU - Europa 888
AS - Asia 489
OC - Oceania 2
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.116
Nazione #
US - Stati Uniti d'America 2.734
CN - Cina 274
PL - Polonia 250
IT - Italia 237
TR - Turchia 115
UA - Ucraina 92
DE - Germania 79
GB - Regno Unito 73
SE - Svezia 55
SG - Singapore 55
BE - Belgio 26
FI - Finlandia 26
RO - Romania 17
ID - Indonesia 16
CZ - Repubblica Ceca 14
VN - Vietnam 13
FR - Francia 9
HK - Hong Kong 8
IE - Irlanda 4
IR - Iran 4
AT - Austria 3
AU - Australia 2
IN - India 2
CA - Canada 1
EE - Estonia 1
EU - Europa 1
KZ - Kazakistan 1
NL - Olanda 1
NO - Norvegia 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 4.116
Città #
Fairfield 430
Woodbridge 349
Warsaw 250
Ann Arbor 222
Houston 219
Ashburn 205
Chandler 203
Seattle 171
Cambridge 135
Wilmington 126
Jacksonville 124
Ferrara 107
Beijing 83
Izmir 66
New York 62
Nanjing 45
Shanghai 39
Milan 38
Princeton 37
Singapore 32
San Diego 27
Brussels 26
Boardman 23
Nanchang 21
Bremen 19
Addison 17
Timisoara 17
Falls Church 16
Jakarta 16
Los Angeles 15
Brno 13
Dong Ket 13
Shenyang 13
Tianjin 12
Changsha 11
Redwood City 10
Dearborn 9
Hebei 9
Hong Kong 8
Kunming 7
London 7
Auburn Hills 6
Bologna 6
Jiaxing 6
Mountain View 6
Washington 6
Ferrara di Monte Baldo 5
Ningbo 5
Cagliari 4
Des Moines 4
Dublin 4
Monza 4
Orange 4
Ardabil 3
Guangzhou 3
Hangzhou 3
Jinan 3
Norwalk 3
San Giorgio Di Piano 3
Stockholm 3
Taizhou 3
Vienna 3
Bergamo 2
Edinburgh 2
Helsinki 2
Kilburn 2
Monte San Pietro 2
Parma 2
Pasadena 2
Rome 2
Salò 2
San Jose 2
Tappahannock 2
Zhengzhou 2
Acton 1
Agna 1
Anzola Dell'emilia 1
Arcene 1
Augusta 1
Berlin 1
Brescia 1
Brookline 1
Caserta 1
Chicago 1
Chiswick 1
Columbus 1
Duncan 1
Hefei 1
Hounslow 1
Indiana 1
Islington 1
Lanzhou 1
Lappeenranta 1
Leawood 1
Monmouth Junction 1
Pavullo Nel Frignano 1
Prescot 1
Redmond 1
San Mateo 1
San Vincenzo 1
Totale 3.389
Nome #
Ruolo del miR-221 nella tumorigenesi epatica 182
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI 179
Absolute quantification of cell-free microRNAs in cancer patients 178
High-sensitivity assay for monitoring ESR1 mutations in circulating cell-free DNA of breast cancer patients receiving endocrine therapy 159
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma 154
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 139
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression 135
Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma 131
Circulating non-coding RNA as biomarkers in colorectal cancer 127
Downregulation of the mitochondrial calcium uniporter by cancer-related miR-25 124
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 123
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: Clinical and biological correlations 122
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations. 121
BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia 119
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics 119
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 116
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 115
MiR-145 participates with TP53 in a death promoting regulatory loop and targets estrogen receptor in human breast cancer cells 112
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations 112
Erratum to: Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations (J Hematol Oncol. (2016) 9 (88) DOI:10.1186/s13045-016-0320-z) 107
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 105
Prediction of response to anti-EGFR antibody-based therapies by multigene sequencing in colorectal cancer patients 105
Oncogenic role of miR-483-3p at the IGF2/483 locus 105
Circulating microRNA quantification using DNA-binding dye chemistry and droplet digital PCR 101
Quantification of Circulating miRNAs by Droplet Digital PCR: Comparison of EvaGreen- and TaqMan-Based Chemistries. 96
HER2-Positive Lobular Versus Ductal Carcinoma of the Breast: Pattern of First Recurrence and Molecular Insights 93
MicroRNA Expression Profiling and Its Clinical Impact in Breast Cancer 92
null 89
Circulating tumor DNAs and non-coding RNAs as potential biomarkers for hepatocellular carcinoma diagnosis, prognosis and response to therapy 87
null 77
Molecular biomarkers predicting early development of endometrial carcinoma: A pilot study 75
Genetic dynamics in untreated CLL patients with either stable or progressive disease: A longitudinal study 73
The importance of microRNAs in RAS oncogenic activation in human cancer 67
Estrogen receptor mutation: a new strategy to overcome endocrine resistance 67
Mutated beta-catenin evades a microRNA-dependent regulatory loop 67
null 63
Molecular testing on bronchial washings for the diagnosis and predictive assessment of lung cancer 43
Inhibiting the oncogenic mir-221 by microRNA sponge: Toward microRNA-based therapeutics for hepatocellular carcinoma 28
How to fish a good micro-marker out from a worthless lake: The case of cell-free miR-181a-5p and breast cancer 27
Monitoring Somatic Genetic Alterations in Circulating Cell-Free DNA/RNA of Patients with "Oncogene-Addicted" Advanced Lung Adenocarcinoma: A Real-World Clinical Study 25
miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs 18
Circulating miR-1246 and miR-485-3p as Promising Biomarkers of Clinical Response and Outcome in Melanoma Patients Treated with Targeted Therapy 16
A microRNA signature to predict risk progression of vulvar lichen sclerosus to squamous cell carcinoma 15
Microbiota and environmental health monitoring of mouse colonies by metagenomic shotgun sequencing 10
Totale 4.218
Categoria #
all - tutte 18.396
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 891
Totale 19.287


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020843 0 32 41 125 83 110 101 87 95 91 45 33
2020/2021798 51 71 54 71 46 80 33 66 24 147 87 68
2021/2022451 23 30 30 23 23 23 45 24 16 33 53 128
2022/2023474 48 41 29 67 66 72 35 31 52 2 17 14
2023/2024332 28 36 11 5 31 85 16 28 7 8 5 72
2024/202553 35 18 0 0 0 0 0 0 0 0 0 0
Totale 4.218